Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Journal of Otolaryngology of Japan

Volumn 108, Issue 2, 2005, Pages 157-163

  Katori, Hideaki ^a   Tsukuda, Mamoru ^b   Ishitoya, Junichi ^a   Mikami, Yasukazu ^b   Matsuda, Hideki ^b   Tanigaki, Yuji ^b   Horiuchi, Chouichi ^b   Ikeda, Youichi ^a   Kimura, Machiko ^a   Taguchi, Takahide ^b   Hirose, Shouji ^a   Yoshida, Takashi ^b   Takahashi, Masahiro ^a   Sakuma, Yasunori ^a   Yamamoto, Kaoru ^a   Sato, Nao ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

5 FU; Chemoradiotherapy; Cisplatin; Docetaxel; Squamous cell carcinoma of the head and neck (SCCHN)

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPENIA; MALE; METASTASIS; MUCOSA INFLAMMATION; NEUTROPENIA; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

EID: 20144380156     PISSN: 00306622     EISSN: None     Source Type: Journal    
DOI: 10.3950/jibiinkoka.108.157     Document Type: Article

References (20)

1. Colevas AD, Busse PM, Norris CM, Fried M, Tisher RB, et al: Induction chemotherapy with docetaxel, cisplatin, fluorouracil and leucovorin for squamous cell carcinoma of head and neck: A phase I/II trial. J Clin Oncol 1998; 16: 1331-1339.
2. Lefebvre J, Chevalier D: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996; 88: 890-898.
3. Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-1689.
4. Kish J, Ensley J: A randomized trial of cisplatin (CACP) +5-fluorouracil (5-FU) infusion and CACP+ 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 1985; 56: 2740-2744.
5. Katori H, Tsukuda M: Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). British J Cancer 2004; 90: 348-352.
6. Colevas AD, Norris CM, Tisher RB, Fried M, Gomolin HI, et al: Pase II trial of docetaxel, cisplatin, fluorouracil and Leucovorin as induction for squamous cell carcinoma of head and neck. J Clin Oncol 1999; 17: 3503-3511.
7. Posner MR, Glisson B, Frenette G, Al-Sarraf M, Colevas AD, et al: Multicenter Phase I-II trial of docetaxel, cisplatin and fluorouracil induction chemotherapy for patients with locally advanced squamous cell carcinoma of head and neck. J Clin Oncol 2001; 19: 1096-1104.
8. Colevas AD, Norris CM, Tisher RB, Lamb CC, Fried MP, et al: Phase I/II trial of outpatient docetaxel, cisplatin, 5-fluorouracil and Leucovorin (opTPFL) as induction for squamous cell carcinoma of head and neck (SCCHN). Am J Clin Oncol 2002; 25: 153-159.
9. Schrijvers D, van Herpen C, Kerger J: Phase I-II study with docetaxel, cisplatin and 5-FU in patients with locally advanced inoperable squamous cell carcinoma of head and neck (SCCHN). Eur J Cancer 1999; 23: 128-131.
10. Jannis J, Papadakou M, Xidakis E: Combination chemotherapy with docetaxel, cisplatin and 5-fluorouracil in previously treated patients with advanced/recurrent head and neck cancer. Am J Clin Oncol 2000; 23: 128-131.
11. Paccagnella A, Orlando A: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994; 86: 265-272.
12. Dreyfuss A, Clark J: Docetaxel: An active drug for squamous cell carcinoma of head and neck. J Clin Oncol 1996; 14: 1672-1678.
13. Forastiere A, Neuberg D: Eastern Cooperative Group (ECOG) pacritaxel studies in advanced head and neck cancer. Head Neck 1994; 16: 481 (abstr 35).
14. Forastiere A, Neuberg D: Phase II evaluation of taxol in advanced head and neck cancer: An Eastern Cooperative Oncology Group trial. Monogor Natl Cancer Inst 1993; 15: 181-184.
15. Catimel G, Verwij J: Docetaxel (taxotere): An active drug for treatment of the treatment of the head and neck. Ann Oncol 1994; 5: 553-557.
16. Couteau C, Leyvraz S: A Phase II study of docetaxel in squamous cell carcinoma (SCO of the head and neck. Proc Am Soc Clin Oncol 1996; 15: 315.
17. Fujii H, Sasaki Y: An early phase II study of docetaxel (Taxotere) in patients with head and neck cancer. Proc Am Soc Clin Oncol 1995; 14: 298 (abstr 859).
18. Mauer A, Masters G: Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol 1998; 16: 159-164.
19. Taylor IV S, Murthy A: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994; 12: 385-395.